Our PFI analysis using Cox regression identified that higher TAGLN2 expression was a risk factor for LGG, KIRC, UVM, PAAD, GBM, LIHC, KICH, THYM, BRCA, KIRP, ACC, and MESO (Figure 3D). This evidence concerns the gene TAGLN2 and pancreatic adenocarcinoma.